Bousquet J, Bourret R, Camuzat T, Augé P, Bringer J, Noguès M, Jonquet O, de la Coussaye J E, Ankri J, Cesari M, Guérin O, Vellas B, Blain H, Arnavielhe S, Avignon A, Combe B, Canovas G, Daien C, Dray G, Dupeyron A, Jeandel C, Laffont I, Laune D, Marion C, Pastor E, Pélissier J Y, Galan B, Reynes J, Reuzeau J C, Bedbrook A, Granier S, Adnet P A, Amouyal M, Alomène B, Bernard P L, Berr C, Caimmi D, Claret P G, Costa D J, Cristol J P, Fesler P, Hève D, Millot-Keurinck J, Morquin D, Ninot G, Picot M C, Raffort N, Roubille F, Sultan A, Touchon J, Attalin V, Azevedo C, Badin M, Bakhti K, Bardy B, Battesti M P, Bobia X, Boegner C, Boichot S, Bonnin H Y, Bouly S, Boubakri C, Bourrain J L, Bourrel G, Bouix V, Bruguière V, Cade S, Camu W, Carre V, Cavalli G, Cayla G, Chiron R, Coignard P, Coroian F, Costa P, Cottalorda J, Coulet B, Coupet A L, Courrouy-Michel M C, Courtet P, Cros V, Cuisinier F, Danko M, Dauenhauer P, Dauzat M, David M, Davy J M, Delignières D, Demoly P, Desplan J, Dujols P, Dupeyron G, Engberink O, Enjalbert M, Fattal C, Fernandes J, Fouletier M, Fraisse P, Gabrion P, Gellerat-Rogier M, Gelis A, Genis C, Giraudeau N, Goucham A Y, Gouzi F, Gressard F, Gris J C, Guillot B, Guiraud D, Handweiler V, Hayot M, Hérisson C, Heroum C, Hoa D, Jacquemin S, Jaber S, Jakovenko D, Jorgensen C, Kouyoudjian P, Lamoureux R, Landreau L, Lapierre M, Larrey D, Laurent C, Léglise M S, Lemaitre J M, Le Quellec A, Leclercq F, Lehmann S, Lognos B, Lussert Cj M, Makinson A, Mandrick K, Mares P, Martin-Gousset P, Matheron A, Mathieu G, Meissonnier M, Mercier G, Messner P, Meunier C, Mondain M, Morales R, Morel J, Mottet D, Nérin P, Nicolas P, Nouvel F, Paccard D, Pandraud G, Pasdelou M P, Pasquié J L, Patte K, Perrey S, Pers Y M, Portejoie F, Pujol J L E, Quantin X, Quéré I, Ramdani S, Ribstein J, Rédini-Martinez I, Richard S, Ritchie K, Riso J P, Rivier F, Robine J M, Rolland C, Royère E, Sablot D, Savy J L, Schifano L, Senesse P, Sicard R, Stephan Y, Strubel D, Tallon G, Tanfin M, Tassery H, Tavares I, Torre K, Tribout V, Uziel A, Van de Perre P, Venail F, Vergne-Richard C, Vergotte G, Vian L, Vialla F, Viart F, Villain M, Viollet E, Ychou M, Mercier J
Professor Jean Bousquet, CHRU, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France, Tel +33 611 42 88 47,
J Frailty Aging. 2016;5(4):233-241. doi: 10.14283/jfa.2016.105.
The Région Languedoc Roussillon is the umbrella organisation for an interconnected and integrated project on active and healthy ageing (AHA). It covers the 3 pillars of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA): (A) Prevention and health promotion, (B) Care and cure, (C) and (D) Active and independent living of elderly people. All sub-activities (poly-pharmacy, falls prevention initiative, prevention of frailty, chronic respiratory diseases, chronic diseases with multimorbidities, chronic infectious diseases, active and independent living and disability) have been included in MACVIA-LR which has a strong political commitment and involves all stakeholders (public, private, patients, policy makers) including CARSAT-LR and the Eurobiomed cluster. It is a Reference Site of the EIP on AHA. The framework of MACVIA-LR has the vision that the prevention and management of chronic diseases is essential for the promotion of AHA and for the reduction of handicap. The main objectives of MACVIA-LR are: (i) to develop innovative solutions for a network of Living labs in order to reduce avoidable hospitalisations and loss of autonomy while improving quality of life, (ii) to disseminate the innovation. The three years of MACVIA-LR activities are reported in this paper.
朗格多克-鲁西永大区是一个关于积极健康老龄化（AHA）的相互关联且整合的项目的总括组织。它涵盖了欧洲积极健康老龄化创新伙伴关系（EIP on AHA）的三大支柱：（A）预防与健康促进，（B）护理与治疗，（C）以及（D）老年人的积极独立生活。所有子活动（多重用药、跌倒预防倡议、衰弱预防、慢性呼吸道疾病、伴有多种疾病的慢性病、慢性传染病、积极独立生活与残疾）都已纳入朗格多克-鲁西永大区积极老龄化与综合健康行动计划（MACVIA-LR），该计划有着坚定的政治承诺，并涉及所有利益相关者（公共部门、私营部门、患者、政策制定者），包括朗格多克-鲁西永大区汽车与社会救助中心（CARSAT-LR）和欧洲生物医学集群。它是EIP on AHA的一个参考站点。MACVIA-LR的框架认为，慢性病的预防和管理对于促进AHA以及减少残疾至关重要。MACVIA-LR的主要目标是：（i）为生活实验室网络开发创新解决方案，以减少可避免的住院率和自主性丧失，同时提高生活质量，（ii）传播创新成果。本文报告了MACVIA-LR三年的活动情况。
